Eugen Rempel
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 7
- Oncology 10
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Albrecht Stenzinger (8 shared papers)Volker Endris (8 shared papers)Stefan Fröhling (6 shared papers)Michael Allgäeuer (7 shared papers)Michael Thomas (5 shared papers)Peter Schirmacher (8 shared papers)Petros Christopoulos (4 shared papers)Olaf Neumann (6 shared papers)
- Journals
- Archives of Toxicology (6 papers)International Journal of Cancer (4 papers)Chemical Research in Toxicology (2 papers)Cancer Research (2 papers)Journal of Thoracic Oncology (2 papers)
- Partner nations
- GermanySwitzerlandUnited Kingdom
In The Last Decade
Eugen Rempel
36 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 595
- Oncology 597
- Developmental Neuroscience 67
- Pulmonary and Respiratory Medicine 375
- Small Animals 88
Countries citing papers authored by Eugen Rempel
This map shows the geographic impact of Eugen Rempel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugen Rempel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugen Rempel more than expected).
Fields of papers citing papers by Eugen Rempel
This network shows the impact of papers produced by Eugen Rempel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugen Rempel. The network helps show where Eugen Rempel may publish in the future.
Co-authors
The 25 scholars most cited alongside Eugen Rempel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 180 | |
| 2 | 2016 | 180 | |
| 3 | 2018 | 154 | |
| 4 | 2018 | 132 | |
| 5 | 2019 | 130 | |
| 6 | 2018 | 93 | |
| 7 | 2019 | 90 | |
| 8 | 2020 | 87 | |
| 9 | 2019 | 85 | |
| 10 | 2014 | 84 | |
| 11 | 2019 | 79 | |
| 12 | 2014 | 77 | |
| 13 | 2015 | 68 | |
| 14 | 2022 | 62 | |
| 15 | 2014 | 60 | |
| 16 | 2017 | 55 | |
| 17 | 2016 | 44 | |
| 18 | 2019 | 44 | |
| 19 | 2020 | 40 | |
| 20 | 2017 | 35 |
About Eugen Rempel
Eugen Rempel is a scholar working on Cancer Research, Oncology, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 2.1k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (8 papers), Cancer Genomics and Diagnostics (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Epigenetics and DNA Methylation (5 papers), Genetic factors in colorectal cancer (4 papers), Lung Cancer Treatments and Mutations (4 papers), CRISPR and Genetic Engineering (3 papers) and Axon Guidance and Neuronal Signaling (2 papers). The work is most often cited by research in Cancer Research (595 citations), Oncology (597 citations), Developmental Neuroscience (67 citations), Pulmonary and Respiratory Medicine (375 citations) and Small Animals (88 citations). Eugen Rempel has collaborated with scholars based in Germany, Switzerland and United Kingdom. Frequent co-authors include Albrecht Stenzinger, Volker Endris, Stefan Fröhling, Michael Allgäeuer, Michael Thomas, Peter Schirmacher, Petros Christopoulos, Olaf Neumann, Martina Kirchner and Anna-Lena Volckmar. Their work appears in journals such as Archives of Toxicology, International Journal of Cancer, Chemical Research in Toxicology, Cancer Research and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.